a(CHEBI:"okadaic acid") decreases a(GO:synapse)

View Subject View Object

PubMed:24653673

In vivo use of phosphatase inhibitors such as okadaic acid has been shown in many studies to induce cognitive impairment and widespread neurotoxic effects that are reminiscent of the hallmark pathological processes occurring in AD pathology, i.e., the accumulation of P-tau, amyloidogenesis, synapse loss and neurodegeneration (Malchiodi-Albedi et al., 1997; Arendt et al., 1998; Sun et al.,2003; Kamat et al.,2013)

Related Edges 5

• a(CHEBI:"okadaic acid") decreases act(complex(GO:"protein phosphatase type 2A complex"))
• a(CHEBI:"okadaic acid") decreases bp(GO:cognition)
• a(CHEBI:"okadaic acid") increases p(HGNC:MAPT, pmod(Ph))
• a(CHEBI:"okadaic acid") increases bp(HBP:amyloidogenesis)
• a(CHEBI:"okadaic acid") increases path(HBP:Neurodegeneration)

BEL Commons is developed and maintained in an academic capacity by Charles Tapley Hoyt and Daniel Domingo-Fernández at the Fraunhofer SCAI Department of Bioinformatics with support from the IMI project, AETIONOMY. It is built on top of PyBEL, an open source project. Please feel free to contact us here to give us feedback or report any issues. Also, see our Publishing Notes and Data Protection information.

If you find BEL Commons useful in your work, please consider citing: Hoyt, C. T., Domingo-Fernández, D., & Hofmann-Apitius, M. (2018). BEL Commons: an environment for exploration and analysis of networks encoded in Biological Expression Language. Database, 2018(3), 1–11.

---